Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSB2400162	Mirikizumab注射液	mirikizumab	Injection	Biological Products(2.2)	Supplementary Application	2024-11-29	Eli Lilly & Company	view
JXSB2400161	Mirikizumab注射液	mirikizumab	Injection	Biological Products(2.2)	Supplementary Application	2024-11-29	Eli Lilly & Company	view
JXSB2400160	Mirikizumab注射液	mirikizumab	Injection	Biological Products(2.2)	Supplementary Application	2024-11-29	Eli Lilly & Company	view
JXSB2300069	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2023-06-07	Eli Lilly & Company	view
JXSB2300051	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2023-05-05	Eli Lilly & Company	view
JXSB2300052	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2023-05-05	Eli Lilly & Company	view
JXSB2300053	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2023-05-05	Eli Lilly & Company	view
JXSB2200109	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2022-09-06	Eli Lilly & Company	view
JXSB2200108	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2022-09-06	Eli Lilly & Company	view
JXSB2200110	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2022-09-06	Eli Lilly & Company	view
JXSB2200082	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2022-06-20	Eli Lilly & Company	view
JXSB2200084	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2022-06-20	Eli Lilly & Company	view
JXSB2200083	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2022-06-20	Eli Lilly & Company	view
JXSB2101111	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2021-12-16	Eli Lilly & Company	view
JXSB2101109	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2021-12-16	Eli Lilly & Company	view
JXSB2101110	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2021-12-16	Eli Lilly & Company	view
JXSB2101070	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2021-10-21	Eli Lilly & Company	view
JXSB2101069	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2021-10-21	Eli Lilly & Company	view
JXSB2101034	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2021-07-13	Eli Lilly & Company	view
JXSB2101032	Mirikizumab注射液	mirikizumab	Injection	Biological Products(1)	Supplementary Application	2021-07-13	Eli Lilly & Company	view